6DO1: PDB entry 6DO1
Structure of nanobody-stabilized angiotensin II type 1 receptor bound to S1I8. Determined by X-ray diffraction at 2.9 Å resolution. Released 30 Jan 2019.
- Method
- X-ray diffraction
- Resolution
- 2.9 Å
- Organisms
- Homo sapiens, Escherichia coli, synthetic construct
- Chains
- 8
- Atoms
- 7,930
- Mol. weight
- 156.22 kDa
- Ligands
- OLC, NAG
- Released
- 30 Jan 2019
Explore 6DO1 in 3D
Show helices and sheets
RCSB PDB
PDBe
Secondary structure: helices and β-sheets
6DO1 contains 34 α-helices and 48 β-strands across 8 chains. Residue ranges use author residue numbering, as in the PDB file, from PDBe. To see them in 3D, choose the Cartoon representation with Secondary structure coloring: helices, sheets and coils get different colors.
Chain A: 15 helices, 4 β-strands
| Element | Residues | Length | Sheet |
|---|
| β-strand | 12-14 | 3 | 1 |
| α-helix | 25-50 | 26 | |
| α-helix | 51-56 | 6 | |
| α-helix | 62-89 | 28 | |
| α-helix | 97-130 | 34 | |
| α-helix | 133-139 | 7 | |
| α-helix | 142-159 | 18 | |
| α-helix | 161-166 | 6 | |
| β-strand | 168-172 | 5 | 1 |
| β-strand | 177-181 | 5 | 1 |
| β-strand | 182-184 | 3 | 2 |
| α-helix | 193-197 | 5 | |
| α-helix | 198-205 | 8 | |
| α-helix | 206-230 | 25 | |
| α-helix | 337-350 | 14 | |
| α-helix | 353-367 | 15 | |
| α-helix | 373-395 | 23 | |
| α-helix | 397-402 | 6 | |
| α-helix | 406-414 | 9 | |
Chain B: 14 helices, 4 β-strands
| Element | Residues | Length | Sheet |
|---|
| β-strand | 12-14 | 3 | 3 |
| α-helix | 30-50 | 21 | |
| α-helix | 51-56 | 6 | |
| α-helix | 62-89 | 28 | |
| α-helix | 97-130 | 34 | |
| α-helix | 133-137 | 5 | |
| α-helix | 142-159 | 18 | |
| α-helix | 161-166 | 6 | |
| β-strand | 168-172 | 5 | 3 |
| β-strand | 177-181 | 5 | 3 |
| β-strand | 182-184 | 3 | 4 |
| α-helix | 193-197 | 5 | |
| α-helix | 198-205 | 8 | |
| α-helix | 206-230 | 25 | |
| α-helix | 337-367 | 31 | |
| α-helix | 373-395 | 23 | |
| α-helix | 397-402 | 6 | |
| α-helix | 406-414 | 9 | |
Chain C: 2 helices, 11 β-strands
| Element | Residues | Length | Sheet |
|---|
| β-strand | 3-7 | 5 | 5 |
| β-strand | 10-12 | 3 | 6 |
| β-strand | 17-25 | 9 | 5 |
| β-strand | 31-39 | 9 | 6 |
| β-strand | 45-52 | 8 | 6 |
| β-strand | 57-59 | 3 | 6 |
| α-helix | 61-63 | 3 | |
| β-strand | 67-72 | 6 | 5 |
| β-strand | 77-83 | 7 | 5 |
| α-helix | 87-89 | 3 | |
| β-strand | 91-99 | 9 | 6 |
| β-strand | 114-116 | 3 | 6 |
| β-strand | 120-124 | 5 | 6 |
Chain D: 2 helices, 11 β-strands
| Element | Residues | Length | Sheet |
|---|
| β-strand | 3-7 | 5 | 7 |
| β-strand | 10-13 | 4 | 8 |
| β-strand | 16-25 | 10 | 7 |
| β-strand | 33-39 | 7 | 8 |
| β-strand | 45-51 | 7 | 8 |
| β-strand | 57-59 | 3 | 8 |
| α-helix | 61-63 | 3 | |
| β-strand | 67-72 | 6 | 7 |
| β-strand | 77-85 | 9 | 7 |
| α-helix | 87-89 | 3 | |
| β-strand | 91-98 | 8 | 8 |
| β-strand | 114-116 | 3 | 8 |
| β-strand | 120-125 | 6 | 8 |
Chain E: 0 helices, 9 β-strands
| Element | Residues | Length | Sheet |
|---|
| β-strand | 6-7 | 2 | 9 |
| β-strand | 21-23 | 3 | 9 |
| β-strand | 34-36 | 3 | 10 |
| β-strand | 49-51 | 3 | 10 |
| β-strand | 77-79 | 3 | 9 |
| β-strand | 92-93 | 2 | 11 |
| β-strand | 95-97 | 3 | 10 |
| β-strand | 115 | 1 | 10 |
| β-strand | 120-121 | 2 | 11 |
Chain F: 1 helix, 7 β-strands
| Element | Residues | Length | Sheet |
|---|
| β-strand | 18-23 | 6 | 12 |
| β-strand | 33-37 | 5 | 13 |
| β-strand | 47-52 | 6 | 13 |
| β-strand | 57-59 | 3 | 13 |
| α-helix | 61-63 | 3 | |
| β-strand | 67-72 | 6 | 12 |
| β-strand | 77-82 | 6 | 12 |
| β-strand | 96-97 | 2 | 13 |
Chains G and H: 0 helices, 1 β-strand
| Element | Residues | Length | Sheet |
|---|
| β-strand | 2-4 | 3 | 4 |
Molecules and chains
| Molecule | Chains | Type | Length | Organism | UniProt |
|---|
| Type-1 angiotensin II receptor,Soluble cytochrome b562 BRIL fusion protein | A, B | protein | 425 | Homo sapiens, Escherichia coli | P0ABE7 (AlphaFold model), P30556 (AlphaFold model) |
| Nanobody Nb.AT110i1 | C, D, E, F | protein | 126 | synthetic construct | |
| Angiotensin-like peptide S1I8 | G, H | protein | 8 | synthetic construct | |
Sequence of entity 1 (A, B), FASTA
>6DO1_1 Type-1 angiotensin II receptor,Soluble cytochrome b562 BRIL fusion protein (chains A, B)
DYKDDDDKILNSSTEDGIKRIQDDCPKAGRHNYIFVMIPTLYSIIFVVGIFGNSLVVIVI
YFYMKLKTVASVFLLNLALADLCFLLTLPLWAVYTAMEYRWPFGNYLCKIASASVSFNLY
ASVFLLTCLSIDRYLAIVHPMKSRLRRTMLVAKVTCIIIWLLAGLASLPAIIHRNVFFIE
NTNITVCAFHYESQNSTLPIGLGLTKNILGFLFPFLIILTSYTLIWKALKKAYDLEDNWE
TLNDNLKVIEKADNAAQVKDALTKMRAAALDAQKATPPKLEDKSPDSPEMKDFRHGFDIL
VGQIDDALKLANEGKVKEAQAAAEQLKTTRNAEIQKNKPRNDDIFKIIMAIVLFFFFSWI
PHQIFTFLDVLIQLGIIRDCRIADIVDTAMPITICIAYFNNCLNPLFYGFLGKKFKRYFL
QLLKY
Sequence of entity 2 (C, D, E, F), FASTA
>6DO1_2 Nanobody Nb.AT110i1 (chains C, D, E, F)
QVQLQESGGGLVQAGGSLRLSCAASGNIFDVDIMGWYRQAPGKERELVASITDGGSTDYA
DSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAAVAYPDIPTYFDYDSDNFYWGQGT
QVTVSS
Sequence of entity 3 (G, H), FASTA
>6DO1_3 Angiotensin-like peptide S1I8 (chains G, H)
GRVYIHPI
Ligands and cofactors
| ID | Name | Formula | Copies |
|---|
| OLC | (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate | C21 H40 O4 | 5 |
| NAG | 2-acetamido-2-deoxy-beta-D-glucopyranose | C8 H15 N O6 | 2 |
Water and common crystallization additives (CL) are not listed.
Primary citation
Distinctive Activation Mechanism for Angiotensin Receptor Revealed by a Synthetic Nanobody. Wingler, L.M., McMahon, C., Staus, D.P. et al. Cell (2019) 176:479-490.e12. DOI 10.1016/j.cell.2018.12.006 · PubMed
Other PDB entries of the same protein (UniProt P0ABE7 (AlphaFold model), which also has an AlphaFold model), best resolution first:
- 6DYF 1.1 Å, Cu(II)-bound structure of the engineered cyt cb562 variant, CH3Y
- 5YO6 1.2 Å, Crystal Structure of B562RIL with engineered disulfide bond T9C-A36C
- 4JEA 1.22 Å, Crystal structure of an engineered Zn-RIDC1 construct with four interfacial disulfide…
- 7LSJ 1.26 Å, Cu-bound crystal structure of the engineered cyt cb562 variant, DiCyt2 - H63A,…
- 7MK4 1.27 Å, Co-bound crystal structure of the engineered cyt cb562 variant, DiCyt2
- 6DYC 1.33 Å, Co(II)-bound structure of the engineered cyt cb562 variant, CH3
- 5YO4 1.37 Å, Crystal Structure of B562RIL with engineered disulfide bond K27C-A79C
- 256B 1.4 Å, Improvement of the 2.5 Å resolution model of cytochrome B562 by redetermining the…
- 6OT4 1.4 Å, Bimetallic dodecameric cage design 2 (BMC2) from cytochrome cb562
- 7LRV 1.4 Å, Ni-bound crystal structure of the engineered cyt cb562 variant, DiCyt2, crystallized in…
- 9PQ4 1.48 Å, Bi-bound structure of the H77C variant of TriCyt2
- 6DYG 1.49 Å, Fe(II)-bound structure of the engineered cyt cb562 variant, CH3Y
Browse structure collections
About this viewer
MolViewer shows 6DO1 directly in your browser with nothing to install. Switch between cartoon, ball-and-stick, spacefill and surface views, color by chain, secondary structure or B-factor, measure distances, angles and dihedrals, and share or embed the view.